The present invention pertains to substances of the formula (I) wherein X is O or S; and R1-R4 are defined in the claims as inhibitors of glyoxalase I and/or II, pharmaceutical compositions comprising one or more compounds according to formula (I) and the use of one or more compounds according to formula (I) for the treatment of diseases associated with increased glycolytic metabolism. In one embodiment, the disease is a fungal infection.
本发明涉及式(I)的物质,其中X是O或S; R1-R4在权利要求中定义为
乙醛酸酯酶I和/或II的
抑制剂,包含一个或多个式(I)化合物的制药组合物以及使用一个或多个式(I)化合物治疗与增加的糖酵解代谢相关的疾病。在一种实施方式中,该疾病是真菌感染。